Furthermore, these tissue specific changes in MRC enzyme activities in both the CNS and peripheral tissues may also be contributory factors to tissue specific pathologies occurring in the EAE mouse as well as in MS patients [51], although this has yet to be investigated. Here, CD200 is linked to myeloid sarcoma.